0001171843-23-001595.txt : 20230310 0001171843-23-001595.hdr.sgml : 20230310 20230310165115 ACCESSION NUMBER: 0001171843-23-001595 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230309 FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blanchard Cheryl R CENTRAL INDEX KEY: 0001326530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 23724421 MAIL ADDRESS: STREET 1: C/O ZIMMER, INC. STREET 2: P.O. BOX 708 CITY: WARSAW STATE: IN ZIP: 46580 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0306 4 2023-03-09 0 0000898437 Anika Therapeutics, Inc. ANIK 0001326530 Blanchard Cheryl R 32 WIGGINS AVENUE BEDFORD MA 01730 1 1 0 0 President, CEO, Director Common Stock 2023-03-09 4 M 0 14419 0 A 87963 D Common Stock 2023-03-09 4 F 0 4232 26.91 D 83731 D Common Stock 11742 I Revocable Trust Restricted Stock Unit 0.00 2023-03-09 4 A 0 60004 0 A Common Stock 60004 60004 D Stock Option (Right to Buy) 29.60 2023-03-09 4 A 0 130998 0 A 2033-03-09 Common Stock 130998 130998 D Restricted Stock Unit 0.00 2023-03-09 4 M 0 14419 0 D Common Stock 14419 14420 D Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 540 shares purchased on May 13, 2022 and 178 shares purchased on November 14, 2022. Reflects an aggregate of 4,232 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023. Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024. Represents a 10% premium above the closing price of Anika's common stock on the date of grant. The premium priced stock options vest in three equal annual installments beginning on March 9, 2024. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. /s/ Cheryl R. Blanchard 2023-03-10